ARDT Stock Analysis: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.10
-0.22 (-2.13%)
▼
5d:
-0.1%
30d:
+6.99%
90d:
+5.21%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ARDT shows positive signals but monitor for confirmation. Market pricing in 2.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ARDT shows positive signals but monitor for confirmation. Market pricing in 2.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.68
Based on 4.8% avg growth
INTRINSIC VALUE TODAY
$7.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.10, which is considered extended relative to its 30-day fair value range of $9.52 to $10.09. The stock's valuation (Forward PE: 7.7) is in line with its historical norms (7.0). At these levels, the market is pricing in 2.8% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. The price is approaching resistance at $10.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.59 (+24.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARDT is in a uptrend. The price is approaching resistance at $10.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.59 (+24.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.52 -
$10.09
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.7% below Wall St target ($12.59)
- BULLISH: Expecting earnings turnaround to 2.8% growth with 7.0% revenue growth
Trading Range Analysis
30-Day Trading Range
$9.52 -
$10.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.31
Resistance Level
$10.38
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.65
Wall Street Target
$12.59
(+24.7%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
-3.4%
Profit Margin
2.1%
Valuation Premium vs History
+2.8% premium
PE vs Historical
7.7 vs 7.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$10.38
(+3%)
2-Year Target
$10.67
(+6%)
3-Year Target
$10.97
(+9%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$10.04
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 5.6%)
$34.31
(+240%)
Base:
(SPY PE: 7.7, Growth: 5.6%)
$11.89
(+18%)
Bear:
(PE: 6.5, Growth: 5.6%)
$10.11
(+0%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 10.86 | Current EPS (TTM): $0.95
Bull Case
$15.77
(+56%)
Analyst growth 38.9%, PE expands to 12.0
Base Case
$14.34
(+42%)
Market implied 38.9%, PE stable at 10.9
Bear Case
$7.02
(-31%)
Severe decline -20.0%, PE contracts to 9.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 8:18 AM ET
Data refreshes hourly during market hours. Next update: 9:18 AM
Data refreshes hourly during market hours. Next update: 9:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$23 | 59 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 59 HOLD |
